Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resistance to Second-Generation HIV-1 Maturation Inhibitors.
Urano E, Timilsina U, Kaplan JA, Ablan S, Ghimire D, Pham P, Kuruppu N, Mandt R, Durell SR, Nitz TJ, Martin DE, Wild CT, Gaur R, Freed EO. Urano E, et al. Among authors: martin de. J Virol. 2019 Mar 5;93(6):e02017-18. doi: 10.1128/JVI.02017-18. Print 2019 Mar 15. J Virol. 2019. PMID: 30567982 Free PMC article.
Determinants of activity of the HIV-1 maturation inhibitor PA-457.
Li F, Zoumplis D, Matallana C, Kilgore NR, Reddick M, Yunus AS, Adamson CS, Salzwedel K, Martin DE, Allaway GP, Freed EO, Wild CT. Li F, et al. Among authors: martin de. Virology. 2006 Dec 5-20;356(1-2):217-24. doi: 10.1016/j.virol.2006.07.023. Epub 2006 Aug 22. Virology. 2006. PMID: 16930665 Free article.
PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.
Li F, Goila-Gaur R, Salzwedel K, Kilgore NR, Reddick M, Matallana C, Castillo A, Zoumplis D, Martin DE, Orenstein JM, Allaway GP, Freed EO, Wild CT. Li F, et al. Among authors: martin de. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60. doi: 10.1073/pnas.2234683100. Epub 2003 Oct 22. Proc Natl Acad Sci U S A. 2003. PMID: 14573704 Free PMC article.
Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection.
Smith PF, Ogundele A, Forrest A, Wilton J, Salzwedel K, Doto J, Allaway GP, Martin DE. Smith PF, et al. Among authors: martin de. Antimicrob Agents Chemother. 2007 Oct;51(10):3574-81. doi: 10.1128/AAC.00152-07. Epub 2007 Jul 16. Antimicrob Agents Chemother. 2007. PMID: 17638699 Free PMC article. Clinical Trial.
312 results